Neuroone Medical Technologies (NMTC) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
11 Sep, 2026Vision and mission
Aims to transform the lives of patients with neurological diseases and chronic pain by providing advanced solutions.
Focuses on under-addressed conditions like epilepsy and trigeminal neuralgia.
Technology and product platform
Proprietary flexible thin film electrode technology enables both diagnostic and therapeutic applications.
Four FDA 510(k) clearances for products addressing brain and pain disorders.
Only FDA-cleared device using the same SEEG electrode for both diagnosis and therapy.
Product portfolio includes Evo Cortical and SEEG Electrodes, OneRF Ablation Systems, and StereoCED Drug Delivery System.
Strategic partnerships and collaborations
Partnership with Zimmer Biomet includes licensing, distribution, and commercialization of SEEG electrodes and OneRF systems.
Mayo Clinic collaboration for pre-clinical and clinical research, with key advisory board members from Mayo.
Latest events from Neuroone Medical Technologies
- Innovative thin film tech and key partnerships fuel growth in epilepsy and pain markets.NMTC
Moody Capital Disruptive Growth & Life Science Conference - Revenue up 16% YoY, gross margin at 59.9%, but net loss and going concern risk remain.NMTC
Q3 2026 - Achieved strong revenue growth, expanded partnerships, and advanced new product launches.NMTC
Investor Update - Transformative neurotechnology enables single-procedure treatments and supports robust growth.NMTC
Planet MicroCap Las Vegas 2026 - Innovative neurology platform drives growth in large, underpenetrated markets with strong partnerships.NMTC
Corporate presentation - Q2 product revenue up 72% to $2.4M, but low cash and losses raise going concern risks.NMTC
Q2 2026 - FDA-cleared thin-film electrode platform drives growth in neurology and pain management markets.NMTC
Corporate presentation - Innovative thin film technology accelerates growth, partnerships, and global expansion plans.NMTC
Oppenheimer 36th Annual Healthcare MedTech & Services Conference - FY2025 revenue to surge on new product launches, expanded partnerships, and strong pipeline.NMTC
Status Update